OrbiMed Capital GP IV LLC, 10% Owner at Relypsa Inc (RLYP), bought 4,361,843 shares at $11.00 ($8.1M) on 2013-11-20, disclosed to the SEC on 2013-11-20.
Open-market purchase of $8.1M RLYP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,904,940 | $0 | 0.0% |
| 2 | $0.17 | 327,133 | $56K | 0.7% |
| 3 | $0.17 | 1,417,578 | $241K | 3.0% |
| 4 | $11.00 | 712,192 | $7.8M | 96.4% |
| Total | $1.86 avg | 4,361,843 | $8.1M | 100% |
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |